Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,170 | 491 | 98.4% |
| Education | $135.67 | 6 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,045 | 65 | $0 (2024) |
| Allergan Inc. | $652.38 | 17 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $603.41 | 21 | $0 (2024) |
| Novo Nordisk Inc | $589.47 | 41 | $0 (2024) |
| ABBVIE INC. | $588.37 | 47 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $573.04 | 31 | $0 (2020) |
| PFIZER INC. | $564.04 | 45 | $0 (2024) |
| Lilly USA, LLC | $428.80 | 30 | $0 (2024) |
| Amgen Inc. | $313.65 | 16 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $292.08 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $994.30 | 71 | ABBVIE INC. ($281.22) |
| 2023 | $988.72 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($142.83) |
| 2022 | $761.84 | 54 | Almatica Pharma LLC ($140.54) |
| 2021 | $660.92 | 47 | AstraZeneca Pharmaceuticals LP ($109.83) |
| 2020 | $491.58 | 34 | AstraZeneca Pharmaceuticals LP ($189.99) |
| 2019 | $1,230 | 59 | Allergan Inc. ($281.38) |
| 2018 | $1,160 | 81 | Allergan Inc. ($164.51) |
| 2017 | $2,019 | 94 | AstraZeneca Pharmaceuticals LP ($310.13) |
All Payment Transactions
497 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: PAIN | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: PAIN | ||||||
| 12/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Insomnia | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Oncology | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: PAIN | ||||||
| 11/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Insomnia | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: PAIN | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Insomnia | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: PAIN | ||||||
| 09/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Insomnia | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 4,373 | 11,202 | $1.3M | $605,438 |
| 2022 | 34 | 4,440 | 11,037 | $1.3M | $598,876 |
| 2021 | 36 | 4,137 | 10,529 | $1.4M | $560,341 |
| 2020 | 32 | 3,572 | 9,807 | $1.2M | $502,899 |
All Medicare Procedures & Services
140 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 417 | 4,049 | $344,165 | $201,327 | 58.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 349 | 854 | $192,150 | $87,268 | 45.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 131 | 820 | $143,500 | $55,397 | 38.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 157 | 487 | $97,400 | $49,481 | 50.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 235 | 235 | $70,500 | $33,417 | 47.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 166 | 206 | $82,400 | $30,469 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 204 | 332 | $58,100 | $24,096 | 41.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 286 | 512 | $48,640 | $19,117 | 39.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 306 | 394 | $59,100 | $17,980 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 72 | $19,800 | $11,126 | 56.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 48 | 50 | $20,000 | $8,825 | 44.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 54 | 55 | $44,000 | $8,069 | 18.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 300 | 300 | $15,000 | $6,246 | 41.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 48 | 58 | $12,180 | $5,715 | 46.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 252 | 252 | $12,600 | $5,247 | 41.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 20 | $9,000 | $4,887 | 54.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 60 | 60 | $4,800 | $4,543 | 94.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 279 | 314 | $28,260 | $3,707 | 13.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 90 | 91 | $3,640 | $3,091 | 84.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $5,100 | $3,078 | 60.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 154 | 227 | $11,350 | $2,675 | 23.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 19 | 19 | $3,275 | $2,477 | 75.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 44 | 52 | $5,320 | $2,335 | 43.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,600 | $2,071 | 57.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 47 | 52 | $5,225 | $1,800 | 34.5% |
About Dr. John Kelly, MD
Dr. John Kelly, MD is a Internal Medicine healthcare provider based in Bloomfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265540686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kelly, MD has received a total of $8,306 in payments from pharmaceutical and medical device companies, with $994.30 received in 2024. These payments were reported across 497 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($8,170).
As a Medicare-enrolled provider, Kelly has provided services to 16,522 Medicare beneficiaries, totaling 42,575 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 140 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bloomfield, NJ
- Active Since 08/27/2006
- Last Updated 08/21/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265540686
Products in Payments
- FARXIGA (Drug) $804.67
- JARDIANCE (Drug) $618.86
- AVYCAZ (Drug) $385.10
- XARELTO (Drug) $354.00
- QUVIVIQ (Drug) $292.08
- QULIPTA (Drug) $236.00
- Ozempic (Drug) $230.04
- INVOKANA (Drug) $219.04
- UBRELVY (Drug) $199.58
- TRULICITY (Drug) $182.07
- CHANTIX (Drug) $178.65
- Aimovig (Biological) $175.33
- NURTEC ODT (Drug) $164.74
- Cologuard Collection Kit (Device) $162.00
- ENTRESTO (Drug) $134.14
- CAM2038 $125.95
- GRALISE (Drug) $125.43
- AFREZZA (Drug) $124.05
- SYMBICORT (Drug) $123.41
- VRAYLAR (Drug) $116.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomfield
Bechara Barrak, Md, MD
Internal Medicine — Payments: $38,899
John Wenceslao, Md, MD
Internal Medicine — Payments: $36,810
Dr. Pranay Bhatt, M.d, M.D
Internal Medicine — Payments: $19,760
Dr. Roy Kellerman, Md, MD
Internal Medicine — Payments: $17,119
Sheila Silverman, Md, MD
Internal Medicine — Payments: $10,559
Edwin Fierer, Md, MD
Internal Medicine — Payments: $8,160